Thorvaldsdottir, B., Mansouri, L., Sutton, L., Nadeu, F., Meggendorfer, M., Parker, H., . . . Rosenquist, R. (2025). ATM aberrations in chronic lymphocytic leukemia: Del(11q) rather than ATM mutations is an adverse-prognostic biomarker.
Citación estilo ChicagoThorvaldsdottir, B., et al. ATM Aberrations in Chronic Lymphocytic Leukemia: Del(11q) Rather Than ATM Mutations Is an Adverse-prognostic Biomarker. 2025.
Cita MLAThorvaldsdottir, B., et al. ATM Aberrations in Chronic Lymphocytic Leukemia: Del(11q) Rather Than ATM Mutations Is an Adverse-prognostic Biomarker. 2025.
Precaución: Estas citas no son 100% exactas.